NCT00677391View on ClinicalTrials.gov

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

PHASE3CompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

November 30, 2004

Conditions

Obesity

Interventions

DRUG

Sibutramine

Capsules, Wk 0: 10mg, once daily; Wks 4-24: 10mg or 15mg, once daily, dosage escalation based upon investigator's assessment.

DRUG

Placebo

Capsules, once daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY